Jay Lichter - 10%+ Owner at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Stock Symbol
JANX on Nasdaq
All Insider Reports
All Insider Reports

Jay Lichter - trading volume in the past year for Janux Therapeutics, Inc.

Holdings reported by Jay Lichter for Janux Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.02M $135M $44.75 Sep 13, 2024 By Avalon BioVentures SPV I, L.P.
Common Stock 2.96M $132M $44.75 Sep 13, 2024 By Avalon Ventures XI, L.P.
Common Stock 573K $25.7M $44.75 Sep 13, 2024 By Avalon BioVentures I, LP
Common Stock 7K $327K $46.68 Sep 13, 2024 Direct
Stock Option (right to buy) 7.68K Sep 13, 2024 Direct Common Stock

Transactions reported by Jay Lichter for Janux Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.